In vivo optical imaging for evaluating the efficacy of edaravone after transient cerebral ischemia in mice

Ning Liu, Jingwei Shang, Fengfeng Tian, Hiroyoshi Nishi, Koji Abe

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Detection and protection of apoptosis, autophagy and neurovascular unit (NVU) are essentially important in understanding and treatment for ischemic stroke patients. In this study, we have conducted an in vivo optical imaging for detecting apoptosis and activation of matrix metalloproteinases (MMPs), then evaluated the protective effect of 2 package types of free radical scavenger edaravone (A and B) on apoptosis, autophagy and NVU in mice after transient middle cerebral artery occlusion (tMCAO). As compared to vehicle treatment, edaravones A and B showed a significant improvement of clinical scores and infarct size at 48 h after 90 min of tMCAO with great reductions of in vivo fluorescent signal for MMPs and early apoptotic annexin V activations. Ex vivo imaging of MMPSense 680 or annexin V-Cy5.5 showed a fluorescent signal, while which was remarkably different between vehicle and edaravone groups, and colocalized with antibody for MMP-9 or annexin V. Edaravone A and B ameliorated the apoptotic neuronal cell death in immunohistochemistry, and activations of MMP-9 and aquaporin 4 with reducing autophagic activations of microtubule-associated protein 1 light chain 3 (LC3) in Western blot. In this study, edaravone in both packages showed a similar strong neuroprotection after cerebral ischemia, which was confirmed with in vivo and ex vivo optical imagings for MMPs and annexin V as well as reducing cerebral infarct, inhibiting apoptotic/autophagic mechanisms, and protecting a part of neurovascular unit.

Original languageEnglish
Pages (from-to)66-75
Number of pages10
JournalBrain Research
Volume1397
DOIs
Publication statusPublished - Jun 23 2011

Fingerprint

Optical Imaging
Transient Ischemic Attack
Annexin A5
Middle Cerebral Artery Infarction
Matrix Metalloproteinase 9
Autophagy
Apoptosis
Matrix Metalloproteinases
Aquaporin 4
Free Radical Scavengers
Microtubule-Associated Proteins
Brain Ischemia
Cell Death
Western Blotting
Immunohistochemistry
Stroke
phenylmethylpyrazolone
Light
Antibodies
Therapeutics

Keywords

  • Apoptosis
  • Autophagy
  • Cerebral ischemia
  • Edaravone
  • In vivo imaging

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

In vivo optical imaging for evaluating the efficacy of edaravone after transient cerebral ischemia in mice. / Liu, Ning; Shang, Jingwei; Tian, Fengfeng; Nishi, Hiroyoshi; Abe, Koji.

In: Brain Research, Vol. 1397, 23.06.2011, p. 66-75.

Research output: Contribution to journalArticle

Liu, Ning ; Shang, Jingwei ; Tian, Fengfeng ; Nishi, Hiroyoshi ; Abe, Koji. / In vivo optical imaging for evaluating the efficacy of edaravone after transient cerebral ischemia in mice. In: Brain Research. 2011 ; Vol. 1397. pp. 66-75.
@article{f352db0aa2e94dcb8613ac5ebda52cae,
title = "In vivo optical imaging for evaluating the efficacy of edaravone after transient cerebral ischemia in mice",
abstract = "Detection and protection of apoptosis, autophagy and neurovascular unit (NVU) are essentially important in understanding and treatment for ischemic stroke patients. In this study, we have conducted an in vivo optical imaging for detecting apoptosis and activation of matrix metalloproteinases (MMPs), then evaluated the protective effect of 2 package types of free radical scavenger edaravone (A and B) on apoptosis, autophagy and NVU in mice after transient middle cerebral artery occlusion (tMCAO). As compared to vehicle treatment, edaravones A and B showed a significant improvement of clinical scores and infarct size at 48 h after 90 min of tMCAO with great reductions of in vivo fluorescent signal for MMPs and early apoptotic annexin V activations. Ex vivo imaging of MMPSense 680 or annexin V-Cy5.5 showed a fluorescent signal, while which was remarkably different between vehicle and edaravone groups, and colocalized with antibody for MMP-9 or annexin V. Edaravone A and B ameliorated the apoptotic neuronal cell death in immunohistochemistry, and activations of MMP-9 and aquaporin 4 with reducing autophagic activations of microtubule-associated protein 1 light chain 3 (LC3) in Western blot. In this study, edaravone in both packages showed a similar strong neuroprotection after cerebral ischemia, which was confirmed with in vivo and ex vivo optical imagings for MMPs and annexin V as well as reducing cerebral infarct, inhibiting apoptotic/autophagic mechanisms, and protecting a part of neurovascular unit.",
keywords = "Apoptosis, Autophagy, Cerebral ischemia, Edaravone, In vivo imaging",
author = "Ning Liu and Jingwei Shang and Fengfeng Tian and Hiroyoshi Nishi and Koji Abe",
year = "2011",
month = "6",
day = "23",
doi = "10.1016/j.brainres.2011.04.038",
language = "English",
volume = "1397",
pages = "66--75",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - In vivo optical imaging for evaluating the efficacy of edaravone after transient cerebral ischemia in mice

AU - Liu, Ning

AU - Shang, Jingwei

AU - Tian, Fengfeng

AU - Nishi, Hiroyoshi

AU - Abe, Koji

PY - 2011/6/23

Y1 - 2011/6/23

N2 - Detection and protection of apoptosis, autophagy and neurovascular unit (NVU) are essentially important in understanding and treatment for ischemic stroke patients. In this study, we have conducted an in vivo optical imaging for detecting apoptosis and activation of matrix metalloproteinases (MMPs), then evaluated the protective effect of 2 package types of free radical scavenger edaravone (A and B) on apoptosis, autophagy and NVU in mice after transient middle cerebral artery occlusion (tMCAO). As compared to vehicle treatment, edaravones A and B showed a significant improvement of clinical scores and infarct size at 48 h after 90 min of tMCAO with great reductions of in vivo fluorescent signal for MMPs and early apoptotic annexin V activations. Ex vivo imaging of MMPSense 680 or annexin V-Cy5.5 showed a fluorescent signal, while which was remarkably different between vehicle and edaravone groups, and colocalized with antibody for MMP-9 or annexin V. Edaravone A and B ameliorated the apoptotic neuronal cell death in immunohistochemistry, and activations of MMP-9 and aquaporin 4 with reducing autophagic activations of microtubule-associated protein 1 light chain 3 (LC3) in Western blot. In this study, edaravone in both packages showed a similar strong neuroprotection after cerebral ischemia, which was confirmed with in vivo and ex vivo optical imagings for MMPs and annexin V as well as reducing cerebral infarct, inhibiting apoptotic/autophagic mechanisms, and protecting a part of neurovascular unit.

AB - Detection and protection of apoptosis, autophagy and neurovascular unit (NVU) are essentially important in understanding and treatment for ischemic stroke patients. In this study, we have conducted an in vivo optical imaging for detecting apoptosis and activation of matrix metalloproteinases (MMPs), then evaluated the protective effect of 2 package types of free radical scavenger edaravone (A and B) on apoptosis, autophagy and NVU in mice after transient middle cerebral artery occlusion (tMCAO). As compared to vehicle treatment, edaravones A and B showed a significant improvement of clinical scores and infarct size at 48 h after 90 min of tMCAO with great reductions of in vivo fluorescent signal for MMPs and early apoptotic annexin V activations. Ex vivo imaging of MMPSense 680 or annexin V-Cy5.5 showed a fluorescent signal, while which was remarkably different between vehicle and edaravone groups, and colocalized with antibody for MMP-9 or annexin V. Edaravone A and B ameliorated the apoptotic neuronal cell death in immunohistochemistry, and activations of MMP-9 and aquaporin 4 with reducing autophagic activations of microtubule-associated protein 1 light chain 3 (LC3) in Western blot. In this study, edaravone in both packages showed a similar strong neuroprotection after cerebral ischemia, which was confirmed with in vivo and ex vivo optical imagings for MMPs and annexin V as well as reducing cerebral infarct, inhibiting apoptotic/autophagic mechanisms, and protecting a part of neurovascular unit.

KW - Apoptosis

KW - Autophagy

KW - Cerebral ischemia

KW - Edaravone

KW - In vivo imaging

UR - http://www.scopus.com/inward/record.url?scp=79958249379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958249379&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2011.04.038

DO - 10.1016/j.brainres.2011.04.038

M3 - Article

C2 - 21571257

AN - SCOPUS:79958249379

VL - 1397

SP - 66

EP - 75

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -